Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Todd Foley


  • Director at Rhythm Pharmaceuticals Inc. (RYTM), 2019-06-21
  • Director at Chiasma Inc (CHMA), 2019-06-17
  • Large Shareholder at Tcr2 Therapeutics Inc. (TCRR), 2019-02-21
  • Large Shareholder at Harpoon Therapeutics Inc. (HARP), 2019-02-14
  • Other at Radius Health Inc. (RDUS), 2016-09-29
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-09
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Trivascular Technologies Inc. (TRIV), 2014-04-23
  • Large Shareholder at Aratana Therapeutics Inc. (PETX), 2014-03-12
  • Large Shareholder at Epizyme Inc. (EPZM), 2014-02-11
  • Director at Celladon Corp (CLDN), 2014-02-06
  • Large Shareholder at Conatus Pharmaceuticals Inc (CNAT), 2013-08-01
  • Other at Pacira Pharmaceuticals Inc. (PCRX), 2013-03-13
  • Director at Zalicus Inc. (ZLCS), 2012-05-25
  • Other at Verastem Inc. (VSTM), 2012-02-03
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RYTM $26.42 378,501 Director 3,074,893 2018-06-25 Filing
RYTM $17.00 100,000 Large Shareholder, Director 2,696,392 2017-10-10 Filing
CLDN $8.00 111,608 Director 1,066,775 2014-02-04 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PETX $19.95 12,539 Large Shareholder 0 2014-03-07 Filing